Expression Analysis, Inc.

Expression Analysis is the industry's leading provider of regulatory compliant microarray-based genomic technology to improve physician's ability to diagnose, treat and manage disease.  Expression Analysis has collaborated with pharmaceutical industry leaders and the FDA to become the first company to submit electronic microarray-based genomic data to the FDA, the first microarray laboratory in the world to meet the requirements of 21CFR Part 58 (Good Laboratory Practices) and the first company in its industry to obtain Clinical Laboratory Improvement Act registration for microarary services.  Expression Analysis is focused on providing regulatory compliant genomic services for clinical trials resulting in tools leading to personalized medicines.